Facebook
Twitter
Telegram
Report an ErrorArbutus Biopharma Corporation Financial Ratios 2011-2024 | ABUS
Annual Financial Ratios Arbutus Biopharma Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-6.1 | -6.1 | -5.4 | -4.7 | -1.0 | -3.6 | -3.3 | -0.4 | -2.3 | -14.8 | -14.1 | 2.2 | -2.5 |
P/S |
24.5 | 10.8 | 37.6 | 43.5 | 26.5 | 34.5 | 26.0 | 90.7 | 5.7 | 38.4 | 12.9 | 4.7 | 1.5 |
EPS |
-0.4 | -0.5 | -0.8 | -1 | -2.9 | -1.2 | -1.6 | -7.2 | -1.4 | -1.8 | -0.9 | 2.2 | -0.9 |
EV (Enterprise Value) |
457 M | 449 M | 339 M | 283 M | 160 M | 196 M | 279 M | 185 M | 141 M | 533 M | 143 M | 31 M | 23.8 M |
EBITDA per Share |
-0.46 | -0.42 | -0.68 | -0.696 | -1.21 | -1.23 | -1.26 | -1.87 | -1.17 | -1.45 | -0.754 | 2.52 | -0.828 |
EV/EBITDA |
-3.4 | -4.5 | -1.8 | -2.5 | -3.5 | -1.2 | 0.5 | -15.5 | -11.3 | 0.6 | -1.6 | ||
PEG |
0.41 | 0.35 | 0.33 | -0.07 | 0.01 | -0.16 | -0.04 | 0.0 | -0.1 | 0.17 | 0.1 | 0.01 | -0.09 |
P/B |
4.2 | 3.1 | 2.4 | 2.9 | 2.2 | 1.0 | 1.5 | 0.7 | 0.3 | 6.5 | 3.4 | 1.6 | 4.7 |
P/CF |
-5.2 | -11.9 | -6.1 | -5.8 | -2.2 | -3.0 | -5.0 | -2.2 | -2.5 | -42.6 | -26.7 | 2.0 | -3.2 |
ROE % |
-68.71 | -50.75 | -45.00 | -62.52 | -211.32 | -28.50 | -46.26 | -189.24 | -11.16 | -44.12 | -23.76 | 73.18 | -186.95 |
ROA % |
-50.45 | -35.54 | -37.29 | -46.50 | -145.66 | -25.04 | -35.59 | -139.23 | -8.58 | -32.86 | -19.61 | 56.93 | -71.02 |
ROCE % |
-73.67 | -47.83 | -43.39 | -44.90 | -73.02 | -32.39 | -31.52 | -37.80 | -7.65 | -33.65 | -20.53 | 80.85 | -150.45 |
Current Ratio |
3.8 | 3.3 | 5.8 | 13.4 | 12.0 | 11.5 | 8.8 | 12.5 | 17.4 | 5.8 | 5.6 | 4.7 | 1.7 |
DSO |
31.5 | 10.5 | 36.7 | 69.3 | 73.1 | 111.7 | 29.7 | 169.9 | 20.3 | 61.7 | 8.7 | 89.0 | 30.6 |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | 23.0 | 15.2 | 20.1 | 11.6 | 19.2 | 18.5 | 19.3 | 20.7 | 16.2 | - |
Operating Cycle |
31.5 | 10.5 | 36.7 | 69.3 | 73.1 | 111.7 | 29.7 | 169.9 | 20.3 | 61.7 | 8.7 | 89.0 | 30.6 |
Cash Conversion Cycle |
31.5 | 10.5 | 36.7 | 46.2 | 57.9 | 91.6 | 18.1 | 150.7 | 1.8 | 42.4 | -12.0 | 72.8 | 30.6 |
All numbers in USD currency
Quarterly Financial Ratios Arbutus Biopharma Corporation
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.1 | - | -0.12 | -0.1 | -0.1 | - | -0.12 | -0.1 | -0.11 | - | -0.24 | -0.23 | -0.21 | - | -0.27 | -0.25 | -0.25 | -0.46 | -1.5 | -0.46 | -0.47 | -0.38 | -0.49 | 0.01 | -0.36 | -0.67 | -0.21 | -0.33 | -0.34 | -4.05 | -0.37 | -2.47 | -0.31 | -0.1 | -0.57 | -0.27 | -0.4 | -0.27 | -0.39 | -0.28 | -0.91 | -0.15 | -0.41 | -0.21 | -0.18 | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.11 | - | - | - | -0.11 | - | -0.11 | -0.09 | -0.07 | - | -0.17 | -0.19 | -0.16 | - | -0.17 | -0.17 | -0.19 | -0.2 | -1.59 | -0.35 | -0.34 | -0.3 | -0.58 | -0.39 | -0.32 | -1.09 | -0.22 | -0.35 | -0.33 | -4.69 | -0.35 | -3.7 | -0.38 | -0.22 | -1.14 | -0.26 | -0.59 | -0.48 | -0.3 | -0.42 | -0.29 | -0.13 | -0.24 | -0.2 | -0.2 | - | - | - | - | - | - | - | - |
ROE % |
-61.98 | -40.89 | -52.96 | -48.19 | -44.76 | -30.85 | -45.57 | -48.22 | -58.18 | -48.30 | -66.69 | -70.36 | -64.95 | -45.80 | -79.69 | -174.72 | -192.95 | -211.32 | -186.54 | -85.35 | -51.76 | -28.50 | -39.07 | -33.21 | -44.76 | -46.26 | -134.30 | -137.59 | -191.63 | -189.24 | -82.47 | -78.11 | -16.79 | -11.16 | -17.21 | -21.69 | -25.88 | -44.12 | -41.49 | -41.70 | -39.88 | -23.76 | -19.37 | -9.39 | -4.30 | - | - | - | - | - | - | - | - |
ROA % |
-46.91 | -30.88 | -39.50 | -35.45 | -32.44 | -21.93 | -33.50 | -29.79 | -44.11 | -37.09 | -50.77 | -52.89 | -48.84 | -34.07 | -57.43 | -121.93 | -133.74 | -145.66 | -130.31 | -62.87 | -39.42 | -25.04 | -32.18 | -26.33 | -35.39 | -35.59 | -99.70 | -101.91 | -141.33 | -139.23 | -60.71 | -57.68 | -12.65 | -8.58 | -13.06 | -16.27 | -19.33 | -32.86 | -31.26 | -32.22 | -31.28 | -19.61 | -15.99 | -7.75 | -3.55 | - | - | - | - | - | - | - | - |
ROCE % |
-66.67 | -43.81 | -56.05 | -50.23 | -45.79 | -28.07 | -42.21 | -44.12 | -53.40 | -46.37 | -61.29 | -62.07 | -56.47 | -40.70 | -58.70 | -168.90 | -184.39 | -197.89 | -188.34 | -79.40 | -62.03 | -44.84 | -69.41 | -60.29 | -59.96 | -60.79 | -154.59 | -156.87 | -242.37 | -242.18 | -117.51 | -118.78 | -25.24 | -18.68 | -28.74 | -25.90 | -33.97 | -37.45 | -29.36 | -27.75 | -22.24 | -20.53 | -16.42 | -10.25 | -5.06 | - | - | - | - | - | - | - | - |
Current Ratio |
4.2 | 3.8 | 4.0 | 4.2 | 4.0 | 3.3 | 3.5 | - | 3.3 | 5.8 | 4.7 | 3.9 | 4.6 | 3.9 | 3.9 | 3.9 | 3.9 | 3.2 | 3.2 | 3.2 | 3.2 | 8.2 | 8.2 | 8.2 | 8.2 | 4.3 | 4.3 | 4.3 | 4.3 | 3.8 | 3.8 | 3.8 | 3.8 | 4.3 | 4.3 | 4.3 | 4.3 | 3.9 | 3.9 | 3.9 | 3.9 | 5.7 | 5.7 | 5.7 | 5.7 | - | - | - | - | - | - | - | - |
DSO |
116.6 | - | 46.9 | 51.8 | 27.4 | - | 14.1 | 4.2 | 8.0 | - | 40.5 | 50.2 | 55.6 | - | 78.6 | 79.1 | 77.0 | 67.9 | 35.9 | 168.2 | 177.1 | 53.5 | 53.5 | 74.9 | 35.6 | 14.5 | 5.3 | 35.3 | 131.1 | -127.8 | 32.2 | 80.6 | 96.9 | 7.2 | 22.6 | 26.7 | 28.4 | 39.9 | 39.8 | 95.9 | 20.8 | 14.2 | 3.6 | 3.8 | 25.5 | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
116.6 | - | 46.9 | 51.8 | 27.4 | - | 14.1 | 4.2 | 8.0 | - | 40.5 | 50.2 | 55.6 | - | 78.6 | 79.1 | 77.0 | 67.9 | 35.9 | 168.2 | 177.1 | 53.5 | 53.5 | 74.9 | 35.6 | 14.5 | 5.3 | 35.3 | 131.1 | -127.8 | 32.2 | 80.6 | 96.9 | 7.2 | 22.6 | 26.7 | 28.4 | 39.9 | 39.8 | 95.9 | 20.8 | 14.2 | 3.6 | 3.8 | 25.5 | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
116.6 | - | 46.9 | 51.8 | 27.4 | - | 14.1 | 4.2 | 8.0 | - | 40.5 | 50.2 | 55.6 | - | 78.6 | 79.1 | 77.0 | 67.9 | 35.9 | 168.2 | 177.1 | 53.5 | 53.5 | 74.9 | 35.6 | 14.5 | 5.3 | 35.3 | 131.1 | -127.8 | 32.2 | 80.6 | 96.9 | 7.2 | 22.6 | 26.7 | 28.4 | 39.9 | 39.8 | 95.9 | 20.8 | 14.2 | 3.6 | 3.8 | 25.5 | - | - | - | - | - | - | - | - |
All numbers in USD currency